SCHEMBL6185905

SCHEMBL6185905

CC(C)(C)OC(=O)N1CCC(N2CCCC(S(=O)(=O)N3CCOCC3)C2)CC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.50
USP2 O75604 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
PIK3CA P42336 2/20 0.47
GPR119 Q8TDV5 5/20 0.41
HPGD P15428 1/20 0.41
USP30 Q70CQ3 1/20 0.40
EPHX1 P07099 1/20 0.39
PARP1 P09874 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3R2 O00459 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
PIK3R5 Q8WYR1 1/20 0.38
PIK3R3 Q92569 1/20 0.38
ADRA1A P35348 1/20 0.37
TP53 P04637 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL190139 0.83 USP2 (0.62) RECQLUSP2SMN1; SMN2GPR119HPGD
SCHEMBL6183048 0.81 RECQL (0.70) RECQLUSP2SMN1; SMN2PIK3CAHPGD
SCHEMBL3212775 0.79 USP2 (0.68) RECQLUSP2SMN1; SMN2PIK3CAGPR119
SCHEMBL31482198 0.77 HPGD (0.49) RECQLGPR119HPGDEPHX1PARP1
SCHEMBL31482233 0.77 HPGD (0.49) RECQLGPR119HPGDEPHX1PARP1
SCHEMBL16845137 0.76 HPGD (0.50) RECQLUSP2SMN1; SMN2GPR119HPGD
SCHEMBL21714446 0.75 RECQL (0.54) RECQLUSP2SMN1; SMN2GPR119HPGD
SCHEMBL31208917 0.75 RECQL (0.54) RECQLUSP2SMN1; SMN2PIK3CAGPR119
SCHEMBL994288 0.75 HPGD (0.58) RECQLUSP2SMN1; SMN2GPR119HPGD
SCHEMBL17128329 0.75 HPGD (0.62) RECQLUSP2SMN1; SMN2GPR119HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6979741-B2 Acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2005-12-27 US disclosed
EP-1478437-B1 ACC INHIBITORS PFIZER PROD INC (US) 2005-08-31 EP disclosed
US-20030187254-A1 Acetyl-CoA carboxylase inhibitors PFIZER INC. 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187254-A1 Acetyl-CoA carboxylase inhibitors ACACA, ACACB, ACAT1 RECQL 2586/4885USP2 2198/4885SMN1; SMN2 4876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.